SVNT Related Earnings
-
Savient Pharmaceuticals (SVNT) Posts Q1 Loss of 34c/Share
-
Savient Pharmaceuticals (SVNT) Posts Q4 Loss of 39c/Share
-
Savient Pharmaceuticals (SVNT) Posts Q3 Loss of 56c/Share
-
Savient Pharmaceuticals (SVNT) Posts Q2 Loss of 23c/Share
-
Savient Pharmaceuticals (SVNT) Misses All Q1 Expectations
-
Savient Pharmaceuticals (SVNT) Posts Q4 Loss of 44c/Sh., Misses Views
-
Savient Pharma (SVNT) Tops Q3 EPS by 1c
-
Savient Pharmaceuticals, Inc. (SVNT) Misses Q2 Loss Views by 13c
-
Savient Pharmaceuticals (SVNT) Tops Q1 Per Share Views
-
Savient Pharma (SVNT) Posts Q4 GAAP Loss of 1c; Launches KRYSTEXXA in U.S.
-
Savient Pharma (SVNT) Posts Q2 Loss of $0.17, Tops Views
-
Savient Pharmaceuticals (SVNT) Reports Q3 Loss of $0.23
-
Savient Pharmaceuticals (SVNT) Reports Q1 Loss of $0.41
-
Savient Pharmaceuticals (SVNT) Reports Q3 Loss of $0.34, Beats the Street by 5c
-
Savient Pharmaceuticals (SVNT) Misses Street's Q2 View
-
Savient Pharmaceuticals (SVNT) Reports Q1 Loss of $0.33
-
Savient Pharmaceuticals (SVNT) Misses Q4 EPS by 4c
-
Savient Pharmaceuticals (SVNT) Tops Q2 EPS by 3c, Revs Light
-
Savient Pharmaceuticals (SVNT) Tops Q1 EPS by 7c
-
Savient Pharma (SVNT) Reports Q4 Loss
-
Savient Pharma (SVNT) Tops Q2 EPS by 9c
-
Savient Pharmaceuticals (SVNT) Reports Q1 EPS
Back to SVNT Stock Lookup
